Work

Phase II study of concurrent cetuximab (C225) plus definitive thoracic radiotherapy (XRT) followed by adjuvant docetaxel in poor prognosis patients with locally advanced non-small cell lung cancer (LA-NSCLC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.7065

Authors: Thomas J. Dilling, Martine Extermann, Jongphil Kim, Lora Thompson, Binglin Yue, Craig William Stevens, Scott Antonia, Jhanelle Elaine Gray, Charles C. Williams, Eric B. Haura, Mary Colleen Pinder, Tawee Tanvetyanon, Alberto Chiappori

Institution: Moffitt Cancer Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601575114

Cites:

Cited by:

Related to: 10